Literature DB >> 26921414

Efficacy and Safety of Oral Fosfomycin for Urinary Tract Infections in Hospitalized Patients.

Shauna Jacobson1, Luis Junco Noa2, Syed Ahmed2, Mark R Wallace2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26921414      PMCID： PMC4775933          DOI： 10.1128/AAC.02971-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  1 in total

1.  Clinical Appraisal of Fosfomycin in the Era of Antimicrobial Resistance.

Authors:  Sangeeta Sastry; Lloyd G Clarke; Hind Alrowais; Ashley M Querry; Kathleen A Shutt; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191
  1 in total
  2 in total

1.  Oral Fosfomycin Efficacy with Variable Urinary Exposures following Single and Multiple Doses against Enterobacterales: the Importance of Heteroresistance for Growth Outcome.

Authors:  Iain J Abbott; Elke van Gorp; Rixt A Wijma; Joseph Meletiadis; Jason A Roberts; Johan W Mouton; Anton Y Peleg
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

Review 2.  Oral and Intravenous Fosfomycin for the Treatment of Complicated Urinary Tract Infections.

Authors:  George G Zhanel; Michael A Zhanel; James A Karlowsky
Journal:  Can J Infect Dis Med Microbiol       Date:  2020-03-28       Impact factor: 2.471
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.